# A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg

> **NCT00241137** · PHASE3 · COMPLETED · sponsor: **Novartis** · enrollment: 3790 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** valsartan

## Key facts

- **NCT ID:** NCT00241137
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-09
- **Primary completion:** 2005-01
- **Final completion:** 2005-01
- **Target enrollment:** 3790 (ACTUAL)
- **Last updated:** 2011-11-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00241137

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00241137, "A Study to Compare Treating Hypertension With Valsartan 160 MG to Valsartan 320 Mg". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT00241137. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*